SEC Form 4 · accession 0001213900-19-000049
DelMar Pharmaceuticals, Inc. · DMPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis M Brown
Officer — Chief Scientific Officer
Period of report
Dec 21, 2018
Accepted (ET)
Jan 2, 2019 · 6:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498382
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2018 | G | 85,000 | $0.00 | D | 133,922 | D | |
| Common Stock | Dec 31, 2018 | J | 169 | $0.3419 | A | 134,091 | D | |
| Common StockF3 | holding | — | — | — | 537,500 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction represents a gift of securities made by the Reporting Person.
- F2The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
- F3Held by Valent Technologies LLC, of which Reporting Person is the sole member and owner and holds sole voting and dispositive power over its shares.